HCA Healthcare (NYSE:HCA) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

HCA Healthcare (NYSE:HCA) had its price target hoisted by analysts at Wells Fargo & Company from $395.00 to $400.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target points to a potential upside of 13.04% from the stock’s previous close.

A number of other analysts have also recently weighed in on HCA. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 1st. TD Cowen reduced their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. UBS Group upped their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Finally, Royal Bank of Canada increased their target price on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Friday, August 23rd. Five investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $379.39.

HCA Healthcare Trading Down 0.6 %

Shares of NYSE:HCA traded down $2.18 during trading on Wednesday, reaching $353.85. 299,464 shares of the stock were exchanged, compared to its average volume of 1,174,601. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. HCA Healthcare has a 12-month low of $226.48 and a 12-month high of $417.14. The firm’s 50-day moving average price is $391.18 and its 200 day moving average price is $355.72. The firm has a market cap of $89.63 billion, a price-to-earnings ratio of 15.99, a price-to-earnings-growth ratio of 1.39 and a beta of 1.68.

Insider Activity

In other news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 1.70% of the company’s stock.

Hedge Funds Weigh In On HCA Healthcare

Several institutional investors have recently modified their holdings of HCA. Terra Nova Asset Management LLC boosted its stake in shares of HCA Healthcare by 0.3% during the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after buying an additional 26 shares during the last quarter. Massmutual Trust Co. FSB ADV boosted its position in shares of HCA Healthcare by 7.4% in the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after acquiring an additional 29 shares during the period. Waldron Private Wealth LLC raised its position in shares of HCA Healthcare by 1.8% in the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after buying an additional 29 shares in the last quarter. Brookstone Capital Management raised its stake in HCA Healthcare by 0.7% in the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after purchasing an additional 30 shares in the last quarter. Finally, UMB Bank n.a. grew its stake in shares of HCA Healthcare by 2.4% during the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after buying an additional 30 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.